Chemical Compound
Cladribine; Adenosine, 2-chloro-2'-deoxy-; 2-Chloro-2'-deoxyadenosine; (2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2-CdA; 2-Chlorodeoxyadenosine; Biodribin; Cladarabine; CldAdo; Jk 6251; Leustat; Leustatin; NSC 105014; NSC 105014-F; RWJ 26251; 2-Chloro-9-(2-deoxy-beta-d-erythro-pentofuranosyl)-9H-purin-6-amine; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
CAS Registry Number
4291-63-8
Primary record
Cladribine; Adenosine, 2-chloro-2'-deoxy-; 2-Chloro-2'-deoxyadenosine; (2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2-CdA; 2-Chlorodeoxyadenosine; Biodribin; Cladarabine; CldAdo; Jk 6251; Leustat; Leustatin; NSC 105014; NSC 105014-F; RWJ 26251; 2-Chloro-9-(2-deoxy-beta-d-erythro-pentofuranosyl)-9H-purin-6-amine; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
- 库存
- 5,277 克
- 纯度
- 98.3 %
- CAS
- 4291-63-8
化合物标识与属性
- CAS
- 4291-63-8
- PubChem CID
- 20279
- SMILES
- C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O
- Canonical SMILES
- Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1
名称与同义词
- Cladribine
- 2-Chloro-2'-deoxyadenosine
- Leustatin
- 2-Chlorodeoxyadenosine
- 4291-63-8
- Litak
- Cladarabine
- cladribina
- mavenclad
- Chlorodeoxyadenosine
- CldAdo
- Cladaribine
- 2-CdA
- cladribinum
- Movectro
- Leustat
- Mylinax
- 2ClAdo
- Cladiribine
- Cladrivine
- Leustatine
- Leustatin (TN)
- 2-chloro-deoxyadenosine
- Cladribine CRS
- 2-Chloro-2'-deoxy-beta-adenosine
- Mavenclad (TN)
- 2 Chlorodeoxyadenosine
- ADENOSINE, 2-CHLORO-2'-DEOXY-
- 2CdA
- Cladribine (Standard)
- 2'-Deoxy-2-chloroadenosine
- C10H12ClN5O3
- CLADRIBINE [MI]
- DTXSID8022828
- Cladribine [USAN:INN:BAN]
- RWJ 26251
- AC1L2FXP
- CLADRIBINE [INN]
- CLADRIBINE [JAN]
- Opera_ID_1191
- RefChem:388887
- CLADRIBINE [HSDB]
- CLADRIBINE [USAN]
- MLS000028377
- CLADRIBINE [VANDF]
- MFCD00153939
- RWJ-26251
- 2-Chloro-2-deoxyadenosine
- D05GJW
- UNII-47M74X9YT5
- CLADRIBINE [MART.]
- SCHEMBL3775
- CCRIS 9374
- DTXCID602828
- PTOAARAWEBMLNO-KVQBGUIXSA-N
- 47M74X9YT5
- Adenosine, 2-chloro-2'-deoxy
- CHEMBL1619
- CLADRIBINE [USP-RS]
- CLADRIBINE [WHO-DD]
- Cladribine (JAN/USP/INN)
- 2-chloro-2'-deoxy-adenosine
- cid_20279
- HSDB 7564
- MLS000028484
- MLS000759397
- MLS001077345
- MLS001424194
- Cladribine (JAN/USAN/INN)
- CLADRIBINE [EMA EPAR]
- Cladribine [USAN:BAN:INN]
- NSC-105014
- CHEBI:567361
- NSC 105014-F
- 2-Chloro-2 -deoxyadenosine
- Cladribine - Bio-X trade mark
- Cladribine [USAN:USP:INN:BAN]
- GTPL4799
- orb1305319
- 2-Chloro-2'-deoxy-D-adenosine
- CLADRIBINE [ORANGE BOOK]
- NSC 105014
- SCHEMBL29355473
- BDBM38920
- C10H12ClN5O3.C3H8
- CTK8D4033
- BRN 0624220
- CLADRIBINE [EP MONOGRAPH]
- CLADRIBINE [USP IMPURITY]
- L01BB04
- L04AA40
- Cladribine CRS (Y0000639)
- Cladribine for peak identification
- NSC105014
- CLADRIBINE [USP MONOGRAPH]
- GLXC-05407
- HMS2052K13
- HMS2232C23
- HMS3715F17
- SMR000058553
- C10-H12-Cl-N5-O3
- ACT02615
- AMY22140
- BCP02868
- CID20279
- NSC105014-F
- ZINC3798064
- Tox21_110834
- Tox21_300596
- CC0168
- CID:20279
- EBC-11113
- HY-13599R
- NSC-05014
- NSC-105014-F
- AKOS015854898
- AKOS015892544
- Cladribine for peak identification CRS
- AC-7591
- ACN-040521
- BCP9000538
- CCG-101116
- CS-2057
- DB00242
- NC00366
- NC06337
- RTC-063884
- RWJ-26251-000
- NCGC00018167-03
- NCGC00022567-05
- NCGC00022567-06
- NCGC00022567-07
- NCGC00022567-08
- NCGC00164384-01
- NCGC00254518-01
- 2-Chloro-2'-deoxyadenosine, antileukemic
- AJ-45639
- AS-12366
- BC164318
- BP-25407
- BR-46529
- CJ-10765
- CPD000058553
- HY-13599
- LS-15109
- SAM001246526
- SC-17356
- SID:57309572
- SY059947
- (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
- CAS-4291-63-8
- AB0011806
- J446.344G
- ST2409775
- TC-063884
- 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
- 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine
- A2187
- NS00005088
- S1199
- SW197746-4
- Leustatin, 2-chlorodeoxyadenosine, Cladribine
- A10223
- D01370
- S-7479
- (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
- 9-(2-Deoxy-b-D-ribofuranosyl)-2-chloroadenine
- AB00382963-17
- AB00382963_19
- (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
- 291C638
- A826062
- D017338
- F078689
- Q414030
- SR-01000003063
- 2-Chloro-2 inverted exclamation mark -deoxyadenosine
- SR-01000003063-7
- 2-Chloro-2'-deoxyadenosine, 99% - 100MG 100mg
- BRD-K93034159-001-25-8
- SR-01000003063-10
- B2693-004182
- Cladribine, European Pharmacopoeia (EP) Reference Standard
- 6-amino-2-chloro-9-(2-deoxy-beta-erythropentofuranosyl)purine
- Cladribine, United States Pharmacopeia (USP) Reference Standard
- (2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
- 6-Amino-2-chloro-9-(2-deoxy-beta-D-arabinofuranosyl)-9H-purine
- 6-amino-2-chloro-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
- (2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxalan-3-ol
- CL9
- Cladribine for peak identification, European Pharmacopoeia (EP) Reference Standard
- 24757-90-2
- 5542-92-7
- Cladribine; Adenosine, 2-chloro-2'-deoxy-; 2-Chloro-2'-deoxyadenosine; (2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2-CdA; 2-Chlorodeoxyadenosine; Biodribin; Cladarabine; CldAdo; Jk 6251; Leustat; Leustatin; NSC 105014; NSC 105014-F; RWJ 26251; 2-Chloro-9-(2-deoxy-beta-d-erythro-pentofuranosyl)-9H-purin-6-amine; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
- Leustatin|||2-Chloro-2'-deoxyadenosine|||2-CdA|||NSC-105014-F|||(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol